Browsing by Author James, Philip

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2004Appropriate Body-Mass Index For Asian Populations And Its Implications For Policy And Intervention StrategiesGill, Timothy; Barba, Corazon; Cavalli-Sforza, Tommaso; Cutter, Jeffrey; Darnton-Hill, Ian; Deurenberg, Paul; Deurenberg-Yap, Mabel; James, Philip; Ko, Gary; Kosulwat, Vongsvat; Kumanyika, Shiriki; Kurpad, Anura; Mascie-Taylor, Nick; Moon, Hyun Kyung; Nakadomo, Fumio; Nishida, Chizuro; Noor, Mohamed Ismail; Reddy, K Srinath; Rush, Elaine; Schultz, Jimaima Tunidau; Seidell, Jaap C; Stevens, June; Swinburn, B A; Tan, Kathryn; Weisell, Robert; Yaynik, C S; Yoshiike, Nobuo; Zhao-su, Wu; Zimmet, Paul Z; Molecular & Microbial BioscienAppropriate Body-Mass Index For Asian Populations And Its Implications For Policy And Intervention Strategies, The Lancet, vol.363,(9403),2004,pp 157-163
2009Differential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trialCaterson, Ian; Anderson, Charlotte; Brendorp, Bente; Finer, Nick; Fosbøl, Emil; James, Philip; Køber, Lars; Rode, Richard; Sharma, Arya; Torp-Pedersen, Christian; Weeke, Peter; School of Molecular BioscienceDifferential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trial, Nutrition & Metabolism, vol.6, 42,pp 9-N/A
2010Early Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead-in PeriodCaterson, Ian; Coutinho, Walmir; Finer, Nick; Ge, Hong; James, Philip; Maggioni, Aldo; Santoro, Donatella; Sharma, Arya; Shepherd, Gillian; Torp-Pedersen, Christian; Van Gaal, Luc; Boden InstituteEarly Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead-in Period, Obesity, vol.18, 5, 2010,pp 987-994
2008Tolerability of Sibutramine During a 6-week Treatment Period in High-Risk Patients With Cardiovascular Disease and/or Diabetes: A Preliminary Analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) TrialCaterson, Ian; Bacher, Peter; Coutinho, Walmir; Finer, Nick; James, Philip; Maggioni, Aldo; Sharma, Arya; Shepherd, Gillian; Sun, Rui; Torp-Pedersen, Christian; Van Gaal, Luc; Boden InstituteTolerability of Sibutramine During a 6-week Treatment Period in High-Risk Patients With Cardiovascular Disease and/or Diabetes: A Preliminary Analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial, Journal of Cardiovascular Pharmacology, vol.52, 5, 2008,pp 393-402
2007Waist circumference thresholds provide an accurate, simple and widely applicable method for the discrimination of diabetesBarzi, Federica; Caterson, Ian; Huxley, Rachel; Woodward, Mark; Azizi, Fereidoun; Gill, Timothy; James, Philip; Kang, JH; Lam, Tai Hing; Lear, Scott; Lee, Crystal M.Y.; Oh, SW; Patel, J; Shaw, Jonathan; Suriyawongpaisal, Paibul; Zimmet, Paul Z; The George Institute for International Health; Molecular & Microbial Bioscien; The George Institute for International Health; The George Institute for International HealthWaist circumference thresholds provide an accurate, simple and widely applicable method for the discrimination of diabetes, Diabetes Care, vol.30,(12),2007,pp 3116-3118
2010The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in periodCaterson, Ian; Andersson, Charlotte; Brendorp, Bente; Finer, Nick; Fosbol, Emil Loldrup; James, Philip; Kober, Lars; Rode, Richard; Sharma, Arya; Torp-Pedersen, Christian; Weeke, Peter; School of Molecular BioscienceThe weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period, BMC Endocrine Disorders, vol.10, 3,pp 1-9